Literature DB >> 1996647

Canine ileocolonic sphincter: flow, transit, and motility before and after sphincterotomy.

M Neri1, S F Phillips, A Fich, A C Haddad.   

Abstract

Our hypothesis was that the canine ileocolonic sphincter (ICS), per se, would have little regulatory effect on the transit of chyme from ileum to colon. We argued, from earlier observations, that the ileocolonic junction was influenced more by functional motor integration of the ileum, ICS, and proximal colon. In five dogs, the ileocolonic sphincter was ablated by extramucosal sphincterotomy; the operation significantly lowered tonic pressures at the ICS. Animals were then studied in the fasting state and postprandially. Ileal flow was estimated by marker dilution, and ileocolonic flow was estimated by total recovery of chyme from a colonic cannula. Transit times were measured after the bolus infusion of nonabsorbable markers. Ileocolonic sphincterotomy did not significantly alter flow rates or transit times of chyme across the ICS, although ileal motor patterns were changed after sphincterotomy. We concluded that the ICS probably has only a small effect on transit and flow at the ileocolonic junction. These findings argue for the importance of integrated motility of the ileum, ICS, and proximal colon in controlling the flow of chyme in this region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996647     DOI: 10.1152/ajpgi.1991.260.2.G284

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Ileocecal segment transposition does not alter whole gut transit in humans.

Authors:  L P Degen; M O von Flüe; A Collet; C Hamel; C Beglinger; F Harder
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

Review 2.  From Chihuahua to Saint-Bernard: how did digestion and microbiota evolve with dog sizes.

Authors:  Charlotte Deschamps; Delphine Humbert; Jürgen Zentek; Sylvain Denis; Nathalie Priymenko; Emmanuelle Apper; Stéphanie Blanquet-Diot
Journal:  Int J Biol Sci       Date:  2022-08-01       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.